NPI: 1144285917 · MILWAUKEE, WI 53208 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/17/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/17/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 37,337 | $865K |
| 2019 | 35,160 | $1.06M |
| 2020 | 34,698 | $1.05M |
| 2021 | 29,398 | $842K |
| 2022 | 23,793 | $845K |
| 2023 | 13,947 | $863K |
| 2024 | 10,640 | $795K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 78,067 | 5,770 | $6.24M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 48,105 | 2,458 | $29K |
| A4657 | Syringe, with or without needle, each | 4,762 | 3,167 | $28K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 521 | 246 | $10K |
| J1756 | Injection, iron sucrose, 1 mg | 12,292 | 2,627 | $6K |
| J1270 | Injection, doxercalciferol, 1 mcg | 27,971 | 2,127 | $3K |
| 90674 | 137 | 114 | $205.92 | |
| 83970 | 2,113 | 1,631 | $48.41 | |
| 82728 | 1,318 | 1,001 | $4.71 | |
| 85041 | 2,644 | 2,002 | $4.10 | |
| 83550 | 1,321 | 1,012 | $3.85 | |
| 85048 | 2,630 | 1,991 | $3.46 | |
| 83540 | 1,374 | 1,044 | $2.86 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 580 | 345 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 152 | 132 | $0.00 |
| 0011A | 24 | 18 | $0.00 | |
| 0012A | 23 | 17 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 924 | 436 | $0.00 |
| 90662 | 15 | 14 | $0.00 |